KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Acadia Pharmaceuticals (ACAD) Interest & Investment Income: 2009-2025

Historic Interest & Investment Income for Acadia Pharmaceuticals (ACAD) over the last 17 years, with Sep 2025 value amounting to $8.2 million.

  • Acadia Pharmaceuticals' Interest & Investment Income rose 25.20% to $8.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.4 million, marking a year-over-year increase of 30.97%. This contributed to the annual value of $25.5 million for FY2024, which is 47.72% up from last year.
  • According to the latest figures from Q3 2025, Acadia Pharmaceuticals' Interest & Investment Income is $8.2 million, which was up 13.85% from $7.2 million recorded in Q2 2025.
  • Acadia Pharmaceuticals' 5-year Interest & Investment Income high stood at $8.2 million for Q3 2025, and its period low was $105,000 during Q1 2022.
  • Over the past 3 years, Acadia Pharmaceuticals' median Interest & Investment Income value was $6.4 million (recorded in 2024), while the average stood at $6.0 million.
  • Per our database at Business Quant, Acadia Pharmaceuticals' Interest & Investment Income crashed by 93.31% in 2021 and then soared by 3,519.05% in 2023.
  • Quarterly analysis of 5 years shows Acadia Pharmaceuticals' Interest & Investment Income stood at $129,000 in 2021, then skyrocketed by 2,713.95% to $3.6 million in 2022, then skyrocketed by 31.10% to $4.8 million in 2023, then soared by 47.24% to $7.0 million in 2024, then rose by 25.20% to $8.2 million in 2025.
  • Its last three reported values are $8.2 million in Q3 2025, $7.2 million for Q2 2025, and $7.9 million during Q1 2025.